Dual-target MSLN/FAP CAR-NK cells

· Beijing Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dual-target MSLN/FAP CAR-NK cells, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma [Phase 1, Phase 2]